This federal contract award, valued at $12,818.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,073,471 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a performance period extending through April 30, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,219.38 firm fixed-price delivery order is for the supply of 10 milliliter vials of the vaccine TYPHIM VI 25 MCG/0.5 ML. The contract has an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $14,044.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,565,159,247 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This contract is not designated as a set-aside and is a firm fixed-price award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $9,363.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,363,711 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract is a firm fixed-price Delivery Order with an ultimate completion date of August 7, 2024. There was no set-aside used for this award. AmerisourceBergen, as the prime contractor, will be responsible for supplying these critical...
This federal contract award, valued at $2,745.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a completion date of December 13, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award, valued at $33,053.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,188,026 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a completion date of October 24, 2024. This is a firm fixed-price delivery order contract, and the award was not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $41,987.15, is for the delivery of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This is a Firm Fixed Price Delivery Order contract with a completion date of February 21, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,139.40 firm fixed-price delivery order is for the supply of 4,568,152,969 units of the vaccine TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The award has a period of performance extending through May 7, 2025. This contract is not designated as a set-aside and is considered an open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,502.31 firm-fixed-price delivery order is for the supply of 4,563,458,750 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMBGH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,027.14, is for the delivery of 10 milliliter vials of the vaccine TYPHIM VI 25 MCG/0.5 ML. This is a firm fixed-price delivery order contract with an ultimate completion date of October 28, 2024. The contract is not designated with a set-aside....